PUBLIC CONTRACT · 2018
BEAD20180219 - Substitutos enzimaticos (exclusivos) - Agalsidase- 2o semestre 2018
- Contract value
- €108,150.00
- Signed on
- 7 May 2018
- Procedure
- Ao abrigo de acordo-quadro (art.º 259.º)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 4677699PUBLISHED SUBJECT
BEAD20180219 - SUBSTITUTOS ENZIMATICOS (EXCLUSIVOS) - AGALSIDASE- 2o SEMESTRE 2018
WHO CONTRACTED
Parties involved
- Place of performance
- Portugal, Região Autónoma da Madeira, Funchal
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- SHIRE PHARMACEUTICALS IBERICA S.L. · Tax ID 509264662
HOW MUCH AND WHEN
Values and timeline
- Contract price
- €108,150.00
- Procedure base price
- €109,702.60
- Total effective price
- €61,800.00
- Publication date
- 23 July 2018
- Award date
- 26 April 2018
- Signing date
- 7 May 2018
- Performance period
- 238 days
The contract price is the value agreed in the contract, not the amount paid.
HOW IT WAS CONTRACTED
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Ao abrigo de acordo-quadro (art.º 259.º)
- Award criterion
- Melhor relação qualidade – preço
- CPV code
- 33690000-3 - Medicamentos vários
- Legal basis
- Artigo 259.º do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos ( DL 111-B/2017 )
- Framework agreement
- CP 2017/58 - Acordo Quadro para fornecimento de Medicamentos para Doenças Lisossomais de Sobrecarga às Instituições e Serviços do Serviço Nacional de Saúde
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 3515103
KEEP EXPLORING
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.